NEONC TECHNOLOGIES HOLDINGS, INC. Amortization of Debt Issuance Costs and Discounts
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Amortization of Debt Issuance Costs and Discounts of $360.12 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $167.95K, a 12.64% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $192.16K, a 66.71% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was -$50.83K.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $391.87K.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $1.11M, a 665.34% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $145.10K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $167.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $360.12K 10-Q · filed 2026-08-10 | $309.29K derived: sum of 3 quarters · filed 2026-08-10 | $701.16K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $192.16K 10-Q · filed 2026-05-15 | $141.34K derived: sum of 2 quarters · filed 2026-05-15 | $533.21K derived: sum of 3 quarters · filed 2026-05-15 | $725.46K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$50.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $341.04K derived: sum of 2 quarters · filed 2026-03-31 | $533.29K derived: sum of 3 quarters · filed 2026-08-10 | $1.11M 10-K · filed 2026-03-31 |
| 2025-09-30 | $391.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $584.12K derived: sum of 2 quarters · filed 2026-08-10 | $1.16M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $192.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $769.44K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $577.19K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $145.10K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |